Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grassroots Biotechnology was an agricultural biotechnology company based in Durham, North Carolina, that specialized in gene expression technologies for crop improvement. The company developed a proprietary platform for creating synthetic promoters, which allow for precise control over when and where genes are activated within a plant. Their research focused on enhancing traits such as yield, drought resistance, and nitrogen use efficiency in crops like corn, soy, and sugarcane. Founded in 2007, the company established significant collaborations with major agricultural players before being acquired by Monsanto in 2013. The acquisition integrated Grassroots' technology into Monsanto's upstream research pipeline to accelerate the development of next-generation biotech traits.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grassroots Biotechnology.